Cite

HARVARD Citation

    Dabbous, O. et al. (n.d.). P.061 The value of AVXS-101 gene-replacement therapy for Spinal Muscular Atrophy Type 1 (SMA1). Canadian journal of neurological sciences. p. S30. [Online]. 
  
Back to record